Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in locally advanced or metastatic epithelial tumors

  1. Juric, D.
  2. Dienstmann, R.
  3. Cervantes, A.
  4. Hidalgo, M.
  5. Messersmith, W.
  6. Blumenschein, G.R.
  7. Tabernero, J.
  8. Roda, D.
  9. Calles, A.
  10. Jimeno, A.
  11. Wang, X.
  12. Bohorquez, S.S.
  13. Leddy, C.
  14. Littman, C.
  15. Kapp, A.V.
  16. Shames, D.S.
  17. Penuel, E.
  18. Amler, L.C.
  19. Pirzkall, A.
  20. Baselga, J.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2015

Volumen: 21

Número: 11

Pages: 2462-2470

Type: Article

DOI: 10.1158/1078-0432.CCR-14-2412 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus